[FeFe] hydrogenases catalyze reversible hydrogen evolution at rates as high as 10,000 turnovers per second. This exceptional catalytic ability is very attractive for the use of hydrogenases in renewable energy applications and biohydrogen production. Unfortunately, enzymes of this class are known to degrade irreversibly upon exposure to small  amounts of oxygen, presenting major roadblocks for study and implementation in practical or industrial applications.

The growing demand for sources of clean and sustainable fuel has been at the forefront of research since the turn of the 21st century. Development of hydrogen fuel cells utilizes hydrogen to meet these demands. Traditionally platinum, the most expensive component, is employed at the cathode of these cells to catalyze the oxygen reduction reaction (ORR). The drive for a cheaper alternative has led to the study of iron porphyrin complexes, inspired by cytochrome c oxidase (CcO), to catalyze ORR.

Positron emission tomography (PET), a nuclear medicine technique, has been applied as an effective clinical tool to diagnose physiological metabolic process based on different functional radiotracers.

DNA sequencing technologies have existed since the early 1970s. The automated Sanger sequencing developed by and named after Frederick Sanger is considered as a “first-generation” technology[1]. Sanger shared 1980 chemistry Nobel prize with Walter Gilbert due to their contributions concerning the determination of base sequences in nucleic acids[2]. The finished-grade Human Genome Project was dominantly supported by Sanger sequencing.

Isolation of circulating tumor cells (CTCs) from blood provides a minimally-invasive alternative for basic understanding, diagnosis, and prognosis of metastatic cancer. The roles and clinical values of CTCs are under intensive investigation, yet most studies are limited by technical challenges in the comprehensive enrichment of intact and viable CTCs with minimal white blood cell (WBC) contamination.

Non-small cell lung cancer (NSCLC) is diagnosed in 187,000 people each year in the United States. Radiation therapy (RT) is a standard care for most patients. However, the maximum radiation dose is limited to ~60-70Gy due to severe side effects such as neutropenic fever and Grade 3 esophagitis.

Glycosaminoglycans (GAGs) are complex linear carbohydrates that participate in a broad range of biological processes.1 Their structural analysis is challenging, and there has been considerable research into tandem MS approaches. Electron activation methods such as electron detachment dissociation (EDD) produce glycosidic fragments and an abundance of cross-ring fragmentation, but this approach is confined to FTICR mass spectrometers.

Charge Detection Mass Spectrometry (CD-MS), quantifies the charge on an individual ion and, from a velocity measurement of each electrostatically accelerated ion, also determines its mass-to-charge ratio. Together these measurements allow a calculation of the mass for a highly charged ion. CD-MS extends the reach of mass spectrometry into the giga Dalton regime. It also allows the analysis of very heterogeneous samples.